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SUMMARY 
Coronary artery disease (CAD) and obesity are both independently associated with impaired 
myocardial systolic function. Epicardial adipose tissue (EAT) volume is another marker of 
visceral adiposity, and is associated with CAD. The association between EAT and myocardial 
systolic dysfunction versus other measures of obesity is unknown. This study showed that 
EAT volume is independently associated with myocardial systolic dysfunction, and may play 
a significant role in pathophysiology of diabetic, obesity and metabolic heart diseases.
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STRUCTURED ABSTRACT 
Background: Although epicardial adipose tissue (EAT) volume is associated with increased 
incidence of coronary artery disease (CAD), its role in myocardial systolic dysfunction is 
unclear. The present study aims to identify independent determinants of EAT volume in 
patients without obstructive CAD, and to evaluate the association between EAT volume 
(versus other measures of obesity) and myocardial systolic strain analysis. 
Methods: 130 patients without obstructive CAD on contrast-enhanced cardiac CT and 
normal left ventricular (LV) ejection fraction (EF) on 3D echocardiography were 
prospectively recruited. EAT volume was quantified from cardiac CT, and 3D 
multidirectional (longitudinal, circumferential, radial and area) strain were measured. 
Results: The mean EAT volume was 97.5±43.7 cm3. On multivariable analysis, measures of 
obesity (body mass index [BMI, p=0.007] and waist/hip ratio [p=0.001]) were independently 
associated with larger EAT volume. EAT volume was correlated with 3D global longitudinal 
(r=0.601, p<0.001), circumferential (r=0.375, p<0.001), radial (r=-0.546, p<0.001) and area 
(r=0.558, p<0.001) strain. On multivariable analyses, epicardial fat volume was the strongest 
predictor of 3D global longitudinal (standardized β=0.512, p<0.001), circumferential 
(standardized β=0.242, p=0.006), radial (standardized β=-0.422, p<0.001), and area 
(standardized β=0.428, p<0.001) strain. In contrast, other measures of obesity including BMI 
and waist/hip ratio were not independent determinants of 3D multidirectional global strain 
(all p>0.05). 
Conclusions: EAT volume is independently associated with impaired myocardial systolic 
function despite preserved 3D LVEF and absence of obstructive CAD, and may play a 
significant role in the pathophysiology of diabetic, obesity and metabolic heart disease. 
Keywords: Mechanics, Epicardial adipose tissue, Systolic strain, Echocardiography, 
Computed tomography 
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INTRODUCTION 
Epicardial adipose tissue (EAT) is located within the pericardial space, bounded by 
the serous epicardium and the fibrous pericardium. Embryologically and biochemically 
different from paracardial mediastinal fat (defined as adipose tissue external to the 
pericardium), EAT is associated with coronary artery disease (CAD), lipotoxic 
cardiomyopathy and atrial fibrillation.1-7 As a metabolically active organ that releases 
cytokines and adipokines into the coronary arteries and myocardium 1-5, EAT may directly 
alter myocardial contractile function independent of CAD. A recent in-vitro study 
demonstrated that EAT explanted from guinea pigs secrete factors that inhibit cardiomyocyte 
contractile function and induce insulin resistance.8 Recent study by Crendal and co-workers 
demonstrated EAT is associated with altered left ventricular (LV) myocardial strain using 2-
dimensional echocardiographic speckle tracking.9 
Two-dimensional speckle tracking longitudinal strain is a highly sensitive marker for 
subclinical myocardial dysfunction, and can predict all-cause mortality in patients with 
normal LV ejection fraction (EF).10-12 In the present study, the authors aimed to identify 
independent determinants of EAT on cardiac CT in patients without obstructive CAD, and 
evaluate the association between EAT and myocardial systolic function using 3-dimensional 
(3D) speckle tracking echocardiographic multidirectional global strain analysis. 
 
METHODS 
Patient population and study protocol 
One hundred and thirty patients with low risk chest pain were prospectively recruited 
to undergo contrast-enhanced cardiac CT and 3D echocardiography. Contrast-enhanced 
cardiac CT was essential for assessing the presence of obstructive CAD, non-obstructive 
CAD and absence of CAD that could potentially confound the echocardiographic 
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multidirectional strain analyses. Cardiac CT examination also included quantification of EAT 
volume. 3D echocardiographic examination included quantifications of 3D LV mass index, 
end-diastolic volume index (EDVI), end-systolic volume index (ESVI), LVEF and 3D 
multidirectional global strain (longitudinal, circumferential, radial and area strain).  
Exclusion criteria included LVEF <50%, previous cardiomyopathies, heart failure, 
moderate or severe valvular heart disease, congenital heart disease, previous history of 
myocardial infarction, percutaneous coronary intervention or coronary artery bypass grafting, 
obstructive CAD on cardiac CT defined as >50% stenosis, atrial fibrillation, and 
contraindications for cardiac CT examination. Contraindications for cardiac CT examination 
included supraventricular or ventricular arrhythmias, renal insufficiency (glomerular filtration 
rate <30 mL/min/1.73m2), iodine contrast allergy, severe claustrophobia, and pregnancy. In 6 
patients with intermediate 50% stenosis, ischemia was excluded by stress echocardiography 
(n=5) or stress technetium-99m sestamibi myocardial perfusion scan (n=1).  
The mean and median dose-length product for the cardiac CT examination (including 
calcium scoring and CT coronary angiography) were 368.2±302.6 mGy.cm and 313.0 
mGy.cm (25th and 75th percentile, 164.0 and 490 mGy.cm) respectively. Using a conversion 
factor of 0.014 for chest CT in adults13, the mean and median estimated effective radiation 
dose were 5.2±4.2 mSv and 4.4 mSv (25th and 75th percentile, 2.3 and 6.9 mSv) respectively. 
The median time difference between cardiac CT and echocardiography was 1.0 month 
(25th and 75th percentile, 0.4 and 1.7 months). 
The study was approved by the institutional ethics committee. 
Cardiac CT data acquisition  
All patients underwent cardiac CT using a dual-source CT system (Somatom 
Definition Flash, Siemens Healthcare, Forchheim, Germany). Cardiac CT was acquired using 
prospective ECG gating triggered at 60% of the R-R interval, with a collimation of 2 x 128 x 
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0.6mm and a gantry rotation time of 280ms. The tube current was 80mA.s and tube voltage 
was 100 kV or 120 kV as determined by patient’s body mass index (BMI). From the raw 
data, cross-sectional images were reconstructed with 0.75mm slice thickness and a soft 
reconstruction kernel (Siemens B26f). 
Patient’s heart rate and blood pressure were monitored prior to each scan and beta-
blockers (25 to 100mg Metoprolol orally) were administered in the absence of 
contraindications. All scans were performed during mid-inspiratory breath-hold and 75mL of 
Ioversol (Optiray 350, Mallinckrodt Medical, St. Louis, MO) was injected. Images were 
subsequently exported to dedicated workstations (SyngoVia, Siemens Healthcare, Forchheim, 
Germany; MASS V2010-EXP, Leiden University Medical Center, Leiden, The Netherlands) 
for off-line post-processing. Agatston calcium score was quantified as per previous 
standard.14 
Epicardial adipose tissue quantification 
For EAT volume quantification, the pericardium was manually traced on every single 
cross-sectional image, starting from the level of pulmonary artery bifurcation to the 
diaphragm (Figure 1). Within these contour limits, a CT attenuation threshold of -50 to -200 
Hounsfield Unit was used to isolate EAT as previous published.15, 16 Mediastinal fat and 
pericardial fat (outside the visceral pericardium and on the external surface of the parietal 
pericardium) were excluded. 
Echocardiography 
Transthoracic echocardiography was performed using a commercially available 
ultrasound system (Vivid E9, 4V probe, GE-Vingmed, Horten, Norway). A complete 2D, 3D, 
color, pulsed and continuous-wave Doppler echocardiogram was performed. Image contrast, 
depth and sector size were optimized for 3D image acquisition to include the entire 
myocardial wall, and an optimal frame rate of >30 frames per second. Images were obtained 
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during breath-hold to achieve a multi-beat 3D volume of a minimum of 4 heartbeats without 
artifacts.17 The mean 3D frame rate was 34.6 frames/sec. All images were digitally stored on 
hard disks for offline analysis. 
3D LV mass index, LVEDVI, and LVESVI were calculated using the 3D dataset and 
corrected for body surface area.18 LVEF was calculated and expressed as a percentage.  
Three-dimensional speckle tracking 
 3D multidirectional global strains were calculated from the 3D dataset using 
commercially available software (4D Auto LVQ, EchoPAC version 113, GE-Vingmed, 
Horten, Norway). Briefly, 3D volume datasets were initially displayed as conventional apical 
and short axis views. Automatic LV border contours were created after placing 2 points, one 
at the center of the LV base and the other at the apex, in the end-diastolic and end-systolic 
apical views. The LV epicardial and endocardial border contours were adjusted if required. 
The motion of the 3D myocardium was subsequently tracked automatically throughout the 
entire cardiac cycle and myocardial deformation was calculated for each segmental volume. 
A multidirectional 17 segments Bull’s eye map with 3D global longitudinal (Figure 2), 
circumferential, radial and area strain results were finally generated and displayed. The 
software will only display 3D multidirectional global strain when ≤3 segments were excluded 
due to inadequate tracking. 
Statistical Analysis 
All continuous variables were tested for Gaussian distribution. Continuous variables 
were presented as mean ± 1 standard deviation unless otherwise stated. Categorical variables 
were presented as frequencies and percentages, and were compared using Chi-square test 
when all expected cell counts were ≥5, or Fisher’s exact test if expected cell count was <5. 
Unpaired Student’s t-test was used to compare 2 groups of continuous variables of Gaussian 
distribution. Pearson correlation was used to determine the association between 2 continuous 
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variables. Multiple linear regression analyses were performed to identify independent 
determinants of both EAT volume and 3D multidirectional global longitudinal, 
circumferential, radial and area strain, with significant univariable determinants entered 
simultaneously as covariates. To avoid multicollinearity, a tolerance of >0.4 was set. As the 
presence of diabetes, hypertension and non-obstructive coronary atherosclerosis may 
potentially confound the multidirectional global strain analyses, these variables were forced 
into all the multivariable models. In addition, to further confirm the study results, all 
multivariable analyses were repeated in patients without diabetes, hypertension and coronary 
atherosclerosis. Similarly, all analyses were repeated in patients with BMI ≤25.0 kg/m2 to 
exclude suboptimal image quality due to obesity as a confounding factor in artificially 
reducing the 3D multidirectional global strain measurements. In 10 randomly selected 
subjects, intra- and inter-observer measurement variabilities for EAT volume and 3D 
multidirectional global strain were presented as mean absolute differences. A 2-tailed p value 
of<0.05 was considered significant. All statistical analyses were performed using IBM SPSS 
Statistics for Windows, version 21.0 (Armonk, NY). 
 
RESULTS 
 The baseline clinical, cardiac CT and echocardiographic characteristics for all the 
patients are shown in Online supplementary Table S1. The mean age was 53±9 years, 53.1% 
male. Men were younger (50±9 vs. 56±8 years, p<0.001) and had significantly higher 
waist/hip ratio (0.97±0.06 vs. 0.89±0.06, p<0.001). 
 The mean EAT volume was 97.5±43.7 cm3 (range 20.0 – 235.2 cm3). Although there 
was a trend towards larger EAT volume in men (103.7±39.5 vs. 90.4±47.4 cm3, p=0.08), 
there were no gender differences in the presence/absence of coronary atherosclerosis (p=0.19) 
or Agatston score (56.2±130.2 vs. 34.6±109.7, p=0.31).  
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Patients with coronary atherosclerosis had significantly larger EAT volume 
(107.4±44.9 vs. 84.4±38.8 cm3, p=0.003). However, there was no correlation between EAT 
volume and Agatston score (r=0.089, p=0.32). 
On 3D echocardiography, men had significantly larger LV volumes and lower 3D 
multidirectional global strain. Although there was a gender difference in LVEF, all patients 
had normal LVEF. 
Determinants of epicardial adipose tissue volume 
 To identify independent determinants of EAT volume, all significant univariable 
determinants (BMI, waist/hip ratio and systolic blood pressure) were simultaneously entered 
into a multiple linear regression model. Table 1 shows that only measures of obesity (BMI 
[p=0.007] and waist/hip ratio [p=0.001]) were independently associated with larger EAT 
volume. 
Determinants of 3D multidirectional global strain 
 Table 2 summarizes all the univariable and multivariable determinants of 3D global 
longitudinal strain. On univariable analysis, patients with coronary atherosclerosis had 
significantly lower 3D global longitudinal strain (-14.9±3.1 vs. -16.1±3.2%, p=0.041). 
However, there was a non-significant association between 3D global longitudinal strain and 
Agatston score (r=0.125, p=0.16). Figure 3 shows the correlation between EAT volume and 
3D global longitudinal strain. 
As the presence of diabetes, hypertension and non-obstructive coronary 
atherosclerosis may potentially confound 3D global longitudinal strain, these variables were 
forced into the multivariable analysis. When all other significant univariable determinants of 
3D global longitudinal strain were entered into the multiple linear regression model (Table 2), 
only EAT volume (standardized β=0.512, p<0.001) and LVESVI (standardized β=0.213, 
p=0.008) were independent determinants of 3D global longitudinal strain. Based on the 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 10
standardized β, EAT volume was the strongest predictor of 3D global longitudinal strain. 
Similar results were obtained showing that EAT volume was an independent determinant of 
3D global circumferential (Table 3), radial (Table 4) and area (Table 5) strain. 
Investigation of possible confounders 
To further confirm that the study findings were not confounded by other potential 
disease mechanisms, all analyses were repeated in patients without diabetes, hypertension 
and coronary atherosclerosis (n=39). EAT volume was still significantly correlated with 3D 
global longitudinal (r=0.538, p<0.001), circumferential (r=0.421, p=0.008), radial (r=-0.579, 
p<0.001), and area (r=0.582, p<0.001) strain. On multivariable analyses, EAT volume was an 
independent determinant of 3D global longitudinal strain (standardized β=0.398, p=0.008). 
Although not significant, larger EAT volume trended towards lower 3D global 
circumferential (standardized β=0.126, p=0.51), radial (standardized β=-0.341, p=0.076), and 
area (standardized β=0.345, p=0.070) strain. 
Obesity will also detrimentally affect image quality and may artificially reduce 3D 
multidirectional global strain measurements. Therefore, patients with BMI ≤25.0 kg/m2 were 
selected (n=40) and all analyses were repeated. EAT volume was still significantly correlated 
with 3D global longitudinal (r=0.668, p<0.001), circumferential (r=0.499, p=0.001), radial 
(r=-0.618, p<0.001), and area (r=0.629, p<0.001) strain. On multivariable analyses, EAT 
volume was an independent determinant of 3D global longitudinal (standardized β=0.414, 
p=0.006), radial (standardized β=-0.547, p=0.006), and area (standardized β=0.575, p=0.003) 
strain. There was also a trend for larger EAT volume and more impaired 3D global 
circumferential strain (standardized β=0.215, p=0.21). 
Finally, increased EAT volume may also have a direct mechanistic effect on 3D 
multidirectional global strain by “constricting” LV systolic and diastolic volumes. However, 
there were no correlations between EAT volume and LVEDVI (r=-0.09, p=0.29) or LVESVI 
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(r=0.08, p=0.35). Furthermore, unlike pericardial constriction where early diastolic velocities 
(E’) by tissue Doppler imaging are usually preserved or even supranormal, there were inverse 
correlations between EAT volume and septal E’ (r=-0.263, p=0.002) and lateral E’ velocities 
(r=-0.285, p=0.001). Therefore, increased EAT volume was unlikely to impair 3D 
multidirectional global strain by physically “constricting” LV systole and diastole. 
Measurement variabilities 
 Online Table S2 outlines the intra- and interobserver measurement variabilities for 
EAT volume and 3D multidirectional global strain analyses. 
 
DISCUSSION 
Previous published studies have clearly demonstrated the independent association 
between EAT and coronary artery disease.1-7 In contrast, the methodological strengths and 
novelties of the present study include: 1) quantification of LV myocardial function using 3D 
speckle tracking echocardiography; 2) quantification of EAT as a 3D volumetric 
measurement from cardiac CT rather than "traditional" 2D echocardiographic thickness 
measurement; 3) demonstrating that increasing obesity was independently associated with 
larger EAT volumes; 4) compared to other measures of obesity including BMI and waist/hip 
ratio, only EAT volume was independently associated with progressively lower 3D 
multidirectional global strain; and 5) the association between larger EAT volume and LV 
myocardial dysfunction was independent of potential confounders including obstructive 
CAD, hypertension, diabetes and obesity. This association is mostly mediated via myocardial 
steatosis and energetic.8 
Physiological and pathophysiological roles of epicardial adipose tissue  
Adipose tissue surrounding the heart can be divided into epicardial and paracardial 
fat.19 Separated by the fibrous pericardium, EAT is bounded between the epicardium and 
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pericardium, whereas paracardial fat is located external to the pericardium. Similar to 
mesenteric and omental visceral fat, EAT is derived from the splanchnopleuric mesoderm 
and is embryologically different from paracardial fat.19 
EAT has several functions affecting the human heart, including functioning as brown 
adipose tissue involved in thermogenesis, as an endocrine and paracrine organ that plays a 
significant role in coronary atherogenesis and inflammation, and as a lipid store that is 
actively involved in myocardial lipid and energy homeostasis, steatosis and lipotoxicity.2, 5  
Epicardial adipose tissue and coronary atherosclerosis 
One of the proposed pathophysiological roles of EAT is the promotion of coronary 
atherogenesis and inflammation.2, 7, 16 As a metabolically active organ, EAT releases 
numerous pro-inflammatory cytokines that promotes atherogenesis.2, 5 Consistent with 
previous publications, this present study demonstrated that patients with coronary 
atherosclerosis had significantly larger EAT volume.7, 15 However, the present study was first 
to demonstrate an inverse relationship between EAT volume and myocardial contractile 
function that is independent of CAD.  
One of the major strength of the present study was the exclusion of CAD as a 
potential confounding factor that could have impaired myocardial contractility. Firstly, all 
patients with obstructive CAD on contrast-enhanced cardiac CT were excluded. Secondly, 
the influence of non-obstructive CAD was evaluated in all the multivariable analyses. Finally, 
the result that EAT was associated with reduced myocardial contractility was confirmed in 
patients with normal coronary arteries (i.e. without any coronary atherosclerosis on cardiac 
CT). Therefore, the association between EAT and reduced myocardial contractility was not 
due to coronary atherosclerosis, but possibly a consequence of its role in myocardial lipid and 
energy homeostasis, steatosis and lipotoxicity. 
Epicardial adipose tissue, myocardial steatosis and contractile dysfunction 
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Diabetes and obesity can lead to intramyocardial triglyceride accumulation (i.e. 
steatosis) in a process synonymous to “fatty liver disease”.20 When the increased availability 
of intramyocardial free fatty acids exceeds its cellular oxidative capacity, there is a resultant 
accumulation of toxic intermediates such as ceramide. Ceramide increases inducible nitric 
oxide synthase activity and intracellular nitric oxide concentration, eventually leading to 
cellular apoptosis. This process is known as lipotoxicity.21  
Previous human physiological study has suggested that EAT may release free fatty 
acids directly into the myocardium, thus playing a role in myocardial lipid and energy 
homeostasis.22 However, increased EAT volume may adversely result in myocardial steatosis 
and lipotoxicity.23 Malavazos and co-workers demonstrated an independent correlation 
between EAT thickness on echocardiography and intramyocardial triglyceride accumulation 
on proton magnetic resonance spectroscopy.23 In turn, it was known that intramyocardial 
triglyceride accumulation was independently associated with subclinical myocardial 
dysfunction in diabetic patients.10 Although previous studies have shown that increased EAT 
was associated with increased LV mass and diastolic dysfunction 10, 24-26, the present study 
demonstrated an inverse independent relationship between EAT and myocardial systolic 
function. Even when patients with diabetes, hypertension and coronary atherosclerosis were 
excluded, EAT volume was still independently correlated with longitudinal myocardial 
function.  
2D versus 3D speckle tracking 
 In the present study, multidirectional myocardial function was quantified using 3D 
speckle tracking. 3D speckle tracking is a relatively new imaging modality and early research 
experience suggests it is not directly comparable to 2D speckle tracking.27 Theoretically, 3D 
speckle tracking provides additional advantages over 2D such as avoidance of foreshortening 
of apical images and out-of-plane motion, and complete quantification of all multidirectional 
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strain analyses from a single volume of interest. However, this is usually at the expense of 
lower volume rate and 3D strain values are not directly comparable with 2D measurements.28 
Study limitations 
 Although the present study demonstrated an independent association between EAT 
volume and impaired 3D multidirectional global strain, it does not necessarily indicate 
increased EAT volume was the cause of the myocardial dysfunction that will eventually lead 
to clinical heart failure. However, previous in-vitro study have demonstrated that EAT 
explanted from guinea pigs secrete factors that inhibited isolated cardiomyocyte contractile 
function and induced insulin resistance.8 Secondly, while the present study suggested that 
increasing obesity was independently associated with larger EAT volumes and larger EAT 
volumes was independently associated with reduced myocardial contractile function, it is 
unclear if increased EAT volume and impaired myocardial function were all a manifestation 
of metabolic syndrome, or represents an independent pathophysiological process. Finally, no 
comparisons were made between the sensitivity of 2D versus 3D echocardiographic speckle 
tracking in detecting myocardial dysfunction. 
Future directions 
 Obesity is known to be associated with myocardial dysfunction and heart failure.29-31 
Although the pathophysiology is unclear, it may be secondary to myocardial steatosis and 
lipotoxicity from fatty acid intermediates such as diacylglycerol and ceramide as seen in 
diabetic patients.10, 32 In the present study, the stronger association between EAT volume and 
myocardial dysfunction compared to BMI and waist/hip ratio suggest EAT may exert a direct 
local paracrine effect on myocardial energetics and contractility.22 Therefore, future studies 
on diabetic, obesity and metabolic heart disease should consider quantification of EAT 
volume by cardiac CT/magnetic resonance imaging, in addition to intramyocardial 
triglyceride content by proton magnetic resonance imaging. Finally, as EAT is known to 
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contain brown adipose tissue, it may potentially have implications for understanding the 
pathogenesis and treatment of obesity and metabolic syndrome.5  
 
CONCLUSIONS 
 EAT volume is a marker of visceral obesity, and is associated with subclinical 
myocardial systolic dysfunction. This association is independent of CAD, diabetes and 
hypertension, and is superior to other measures of obesity such as BMI and waist/hip ratio. 
Future studies on diabetic, obesity and metabolic heart diseases should include quantification 
of EAT volume when evaluating LV myocardial function. 
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Figure legends 
 
Figure 1. Quantification of epicardial adipose tissue on cardiac CT.  
Epicardial adipose tissue is defined as fat between the heart and the fibrous pericardium, 
whereas paracardial adipose tissue is external to the pericardium (left panel). Contours were 
drawn along the pericardium and epicardial adipose tissue is automatically identified by the 
software (red color) (right panel). 
 
 
Figure 2. Examples of epicardial adipose tissue volumes and 3D speckle tracking in 2 female 
patients. Both patients had comparable LV mass index, volumes and EF, but 3D global 
longitudinal strain was significantly more impaired in the patient with larger epicardial 
adipose tissue volume. 3D: 3-dimensional; LV: left ventricular; EAT: epicardial adipose 
tissue; EDVI: end-diastolic volume index; ESVI: end-systolic volume index; EF: ejection 
fraction; LVMI: left ventricular mass index; GLS: global longitudinal strain. 
 
 
Figure 3. Correlation between epicardial adipose tissue volume and 3D global longitudinal 
strain. Patients with larger epicardial adipose tissue volume have significantly more impaired 
myocardial function despite a preserved LVEF. 3D: 3-dimensional. 
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Table 1. Univariable and multivariable linear regression models for epicardial adipose tissue 
volume 
 Univariable Multivariable 
Variable Standardized β p value Standardized β p value 
Body mass index 0.382 <0.001 0.230 0.007 
Waist/hip ratio 0.359 <0.001 0.266 0.001 
Systolic BP 0.305 <0.001 0.129 0.18 
Diastolic BP 0.316 <0.001 0.131 0.17 
BP: blood pressure 
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Table 2. Univariable and multivariable linear regression models for 3-dimensional global longitudinal strain 
 Univariable Multivariable 
 Standardized β p value Standardized β p value 
Male gender 0.294 0.001 0.114 0.23 
Hypertension 0.180 0.040 0.115 0.14 
Diabetes 0.164 0.06 0.080 0.26 
Body mass index 0.215 0.014 -0.108 0.17 
Waist/hip ratio 0.361 <0.001 0.080 0.38 
Systolic BP 0.324 <0.001 0.064 0.46 
Diastolic BP 0.298 0.001 0.078 0.34 
LVESVI 0.350 <0.001 0.213 0.008 
Presence of coronary atherosclerosis 0.179 0.041 -0.016 0.83 
Epicardial adipose tissue volume 0.601 <0.001 0.512 <0.001 
BP: blood pressure; ESVI: end-systolic volume index; LV: left ventricular.  
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Table 3. Univariable and multivariable linear regression models for 3-dimensional global circumferential strain 
 Univariable Multivariable 
 Standardized β p value Standardized β p value 
Hypertension 0.299 0.001 0.243 0.003 
Diabetes 0.228 0.009 0.090 0.25 
Body mass index 0.283 0.001 -0.011 0.90 
Waist/hip ratio 0.271 0.002 0.102 0.21 
Systolic BP 0.230 0.009 -0.072 0.43 
Diastolic BP 0.233 0.008 0.107 0.23 
LV mass index -0.194 0.027 -0.179 0.024 
LVESVI 0.429 <0.001 0.350 <0.001 
Presence of coronary atherosclerosis 0.055 0.54 -0.061 0.42 
Epicardial adipose tissue volume 0.375 <0.001 0.242 0.006 
BP: blood pressure; ESVI: end-systolic volume index; LV: left ventricular.  
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Table 4. Univariable and multivariable linear regression models for 3-dimensional global radial strain 
 Univariable Multivariable 
 Standardized β p value Standardized β p value 
Male gender -0.211 0.016 0.020 0.83 
Hypertension -0.245 0.005 -0.179 0.022 
Diabetes -0.220 0.012 -0.088 0.22 
Body mass index -0.296 0.001 0.070 0.39 
Waist/hip ratio -0.353 <0.001 -0.149 0.10 
Systolic BP -0.283 0.001 0.041 0.63 
Diastolic BP -0.297 0.001 -0.126 0.12 
LV mass index 0.186 0.034 0.166 0.024 
LVESVI -0.393 <0.001 -0.312 <0.001 
Presence of coronary atherosclerosis -0.115 0.19 0.051 0.47 
Epicardial adipose tissue volume -0.546 <0.001 -0.422 <0.001 
BP: blood pressure; ESVI: end-systolic volume index; LV: left ventricular.  
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Table 5. Univariable and multivariable linear regression models for 3-dimensional global area strain 
 Univariable Multivariable 
 Standardized β p value Standardized β p value 
Male gender 0.209 0.017 0.006 0.95 
Hypertension 0.252 0.004 0.179 0.022 
Diabetes 0.221 0.011 0.087 0.23 
Body mass index 0.308 <0.001 -0.053 0.52 
Waist/hip ratio 0.341 <0.001 0.116 0.20 
Systolic BP 0.289 0.001 -0.032 0.71 
Diastolic BP 0.302 <0.001 0.123 0.13 
LV mass index -0.206 0.019 -0.174 0.018 
LVESVI 0.374 <0.001 0.284 <0.001 
Presence of coronary atherosclerosis 0.133 0.13 -0.027 0.70 
Epicardial adipose tissue volume 0.558 <0.001 0.428 <0.001 
BP: blood pressure; ESVI: end-systolic volume index; LV: left ventricular.  
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